ETF MANAGERS GROUP, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 114 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2022$777,000
-56.5%
4,710,319
-33.3%
0.02%
-51.9%
Q2 2022$1,787,000
-69.2%
7,062,485
-37.6%
0.05%
-55.2%
Q1 2022$5,795,000
-32.1%
11,323,000
-19.9%
0.12%
-31.4%
Q4 2021$8,534,000
-40.1%
14,138,998
+0.3%
0.17%
-36.9%
Q3 2021$14,243,000
-45.1%
14,101,511
-0.1%
0.27%
-36.6%
Q2 2021$25,966,000
+118.9%
14,111,782
+134.4%
0.42%
+100.5%
Q1 2021$11,860,000
+17.1%
6,020,395
-25.7%
0.21%
-5.0%
Q4 2020$10,130,000
+54.2%
8,103,641
+122.0%
0.22%
+6.7%
Q3 2020$6,569,000
-78.9%
3,649,648
-1.6%
0.21%
-81.1%
Q2 2020$31,109,000
+66.4%
3,707,912
+3.9%
1.10%
+27.2%
Q1 2020$18,698,000
-40.7%
3,568,345
-38.3%
0.87%
-21.0%
Q4 2019$31,557,000
-5.9%
5,779,642
-16.1%
1.10%
-9.0%
Q3 2019$33,551,000
-30.9%
6,889,360
-1.7%
1.21%
-22.0%
Q2 2019$48,587,000
+108.7%
7,011,051
+77.1%
1.55%
+41.3%
Q4 2018$23,276,000
+27609.5%
3,958,561
+116.3%
1.10%
+18150.0%
Q2 2018$84,000
-99.4%
1,830,450
-25.5%
0.01%
-99.3%
Q1 2018$14,496,000
+700.9%
2,456,921
+979.1%
0.88%
+570.2%
Q4 2017$1,810,000227,6760.13%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders